Gene: RFLNA
Official Full Name: refilin Aprovided by HGNC
Gene Summary: Predicted to enable filamin binding activity. Predicted to be involved in several processes, including actin filament bundle organization; negative regulation of bone mineralization involved in bone maturation; and negative regulation of chondrocyte development. Predicted to be located in cytoplasm and cytoskeleton. Predicted to be active in actin filament bundle. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA04749 | RFLNA Knockout cell line (AC16) | Human | RFLNA | 1:3-1:4 | negative | Online Inquiry |
| KOA20193 | RFLNA Knockout cell line (BEAS-2B) | Human | RFLNA | 1:3~1:4 | negative | Online Inquiry |
| KOA35641 | RFLNA Knockout cell line (U-2932) | Human | RFLNA | 1:2-1:4 | negative | Online Inquiry |
| KOA51048 | RFLNA Knockout cell line (TPC-1) | Human | RFLNA | 1:5-1:8 | negative | Online Inquiry |
| KOA66454 | RFLNA Knockout cell line (NCM460) | Human | RFLNA | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.